drugset / Trial / NCT00883155
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets under Fasting Conditions.
Timeline
- Start
- 1998-10
- Primary completion
- 1998-10
- Completion
- 1998-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 100 mg | — |
Indications
No indication recorded.